Received Oct 16, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| UNK | VACCINE NOT SPECIFIED (NO BRAND NAME) | UNKNOWN MANUFACTURER | UNK | U8832DA | OT |
accidental exposure because pharmacy staff member inadvertently may have gotten vaccine in his eye with no reported ae; accidental exposure because pharmacy staff member inadvertently may have gotten vaccine in his eye with no reported adverse event; Initial information received on 10-Oct-2025 regarding an unsolicited valid non-serious case received from a pharmacist. This case involves a 21 years old male patient who had accidental exposure because pharmacy staff member inadvertently may have gotten vaccine in his eye with no reported adverse event while they took the rubber stopper off the influenza trivalent recombinant vaccine [Flublok TIV]. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On 10-Oct-2025, the influenza trivalent recombinant vaccine, Solution for injection strength: not reported (lot U8832DA; expiry date: 31-May-2026) for Immunization, accidental exposure because pharmacy staff member inadvertently may have gotten vaccine in his eye no reported adverse event (accidental exposure to product) (exposure via eye contact) (latency: same day). Reporter states that a 21 year old male pharmacy technician took the rubber stopper off of the FLUBLOK, and may have gotten an exceedingly small amount of the product in his left eye today (10-Oct-2025). He is not experiencing any side effects at this time. Action taken: Not applicable. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.